TD Original

Building Better Killing Machines — With Ecstasy!

Russell Hausfeld / Truthdig Mar 21, 2024 Rick Doblin, the pioneer of MDMA therapy, advocates for dosing soldiers upon enlistment. Dig deeper ( 4 Min. Read )

Ear to the Ground

Corporadelic: MAPS For-Profit Arm Raises $100 Million

Russell Hausfeld / Truthdig Jan 11, 2024 The pioneering psychedelics advocacy group has traded its “public benefit model” for one closer to traditional pharma. Dig deeper ( 3 Min. Read )

Interview

How the Psychedelic Movement Disregards Indigenous Knowledge

Joseph Lee / The Microdose Jul 11, 2023 Five questions for Indigenous protester Kuthoomi Castro. Dig deeper ( 5 Min. Read )

TD Original

Part II: Who’s Researching the Researchers?

Russell Hausfeld / Truthdig Mar 23, 2023 This is the concluding feature story in the multi-part Dig series, “The Ecstasy of Agony,” investigating the politics of psychedelic research and its commercialization, with a focus on the historic and present-day links between psychedelia and the military. The first feature explored how veterans were deployed by the Multidisciplinary Association for Psychedelic Studies' (MAPS) as public relations mascots to gain public sympathy for psychedelic pharmaceutical agendas. This piece delves deeper into the lived experiences of veterans recruited by MAPS and explores allegations of manipulation tactics on the part of MAPS and its researchers — allegations that raise serious questions about MAPS' methods and relationships with veterans over the last decade. Dig deeper ( 21 Min. Read )

TD Original

The Psychedelic Renaissance and the Military

Staff / Truthdig Feb 17, 2023 The video and full transcript from Truthdig's recent livestream event featuring a discussion between Psymposia co-founder, Brian Normand, and Dig curator, Russell Hausfeld. Dig deeper ( 22 Min. Read )

Politics

Corporadelia is Knocking at Psychedelia’s Door

Russell Hausfeld / Truthdig Feb 8, 2023 A conversation with psychedelic activist David Nickles about “Non-Prohibitionist Critique” and the dangers of right-wing appropriation of experimental drug treatments. Dig deeper ( 11 Min. Read )

Health & Wellness

The Importance of “Breakthrough” Designation in Drug Policy

Russell Hausfeld / Truthdig Dec 15, 2022 What’s good for Pharma isn’t always good for average drug users. Dig deeper ( 4 Min. Read )

TD Original

Psychedelics, Alone, Will Not Save Us From Dystopia

Russell Hausfeld / Truthdig Dec 2, 2022 Dispelling the myth that psychedelics will usher in a progressive utopia without accompanying political activity aimed at systemic socioeconomic change. Dig deeper ( 3 Min. Read )

TD Original

Has the military been secretly conducting its own MDMA studies?

Russell Hausfeld / Truthdig Nov 30, 2022 In previously unreported statements made at the 2017 International Drug Policy Reform Conference, Rick Doblin, executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), discussed rumors of secret Pentagon studies with MDMA, as well as the reasons for hesitancy on the part of some government agencies to fund MAPS’ research. Dig deeper ( 2 Min. Read )

TD Original

MAPS advances its agenda to treat active-duty soldiers with psychedelics

Russell Hausfeld / Truthdig Nov 10, 2022 Dig deeper ( 2 Min. Read )